With N.Y. doctor cleared of Ebola, there are no known cases in U.S.

 

The physician who treated Ebola patients in West Africa before returning to New York City has been deemed clear of Ebola, meaning that the U.S. currently has no known cases of the virus.

Read more below:

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.